What are the expected impacts?

The current and emerging findings will converge and substantiate the development of tools and technologies for personalised healthcare and a dynamic life-course model based on GPA status. These outputs, supported by econometric studies within DynaHEALTH, will also enable the development of evidence-based policy recommendations. The recommendations, validated by robust research, have the potential to influence the future direction of European healthcare policymaking, through personalised medicine and informed interventions during the life-course, to address the future economic and societal burden of obesity and type 2 diabetes.